Distribuzione geografica
Continente #
EU - Europa 4.293
Totale 4.293
Nazione #
IT - Italia 4.293
Totale 4.293
Città #
Genova 3.483
Rapallo 434
Genoa 367
Bordighera 9
Totale 4.293
Nome #
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma 163
Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects 157
Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas 150
Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm 149
Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells 143
Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. 137
Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells 136
Basic fibroblast growth factor activates endothelial nitric-oxide synthase in CHO-K1 cells via the activation of ceramide synthesis 134
Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets 131
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current 127
SDF1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent cytosolic tyrosine kinase, Pyk2. 126
Adiponectin as Novel Regulator of Cell Proliferation in Human Glioblastoma 122
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures 117
Inhibition of chloride intracellular channel 1 (CLIC1) as biguanide class-effect to impair human glioblastoma stem cell viability 116
The phosphotyrosine phosphatase PTPh mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2 113
Molecular pharmacology of malignant pleural mesothelioma: Challenges and perspectives from preclinical and clinical studies 112
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas 108
The Eighth Fibronectin Type III Domain of Protein Tyrosine Phosphatase Receptor J Influences the Formation of Protein Complexes and Cell Localization. 107
Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors 106
Primary Cultures from Human GH-secreting or Clinically Non-functioning Pituitary Adenomas 106
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease 105
Chemokine stromal cell-derived factor 1α induces proliferation and growth hormone release in GH4C1 rat pituitary adenoma cell line through multiple intracellular signals 101
The chemokine SDF1/CXCL12: a novel autocrine/paracrine factor involved in pituitary adenoma development 100
Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature 100
Somatostatin receptor 1, 2 and 5 activation leads to C6 glioma growth arrest in vitro and in vivo: analysis of the intracellular pathways involved 99
Differential role of EGF and bFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensitivity 99
Mutual influence of ROS, pH and CLIC1 membrane protein in the regulation of G1/S phase progression in human glioblastoma stem cells 98
Chronic lymphocytic leukemic (CLL) B cells express the HGF receptor (C-MET) and are supported in their survival by HGF-producing mesenchymal stromal cell 97
Different response of human glioma tumor-initiating cells to EGFR kinase inhibitors. 95
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation 93
An intracellular multi-effector complex mediates somatostatin receptor 1 regulation of phospho-tyrosine phosphatase eta activity 92
Canine osteosarcoma cell lines contain stem-like cancer cells: Biological and pharmacological characterization 90
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation 88
CXC receptors and chemokines expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation 85
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 73
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives 72
The activation of the phosphotyrosine phosphatase h (r-PTPh) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation 69
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt 67
Somatostatin receptors 1, 2 and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro, via a PTPh-dependent inhibition of ERK1/2. 66
Somatostatin receptor subtype-dependent regulation of NO release: involvement of different intracellular pathways 53
The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation 37
Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro 4
Mutual influence of ROS, PH, and CLIC1 membrane protein in the regulation of G 1 -S phase progression in human glioblastoma stem cells 2
Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function 2
Metformin potentiates immunosuppressant activity and adipogenic differentiation of human umbilical cord-mesenchymal stem cells 1
Totale 4.426
Categoria #
all - tutte 11.470
article - articoli 11.470
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.940

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019254 0 0 0 0 0 0 0 0 0 50 113 91
2019/20201.149 40 33 41 75 105 133 175 77 112 185 139 34
2020/2021387 22 39 40 24 50 17 19 23 26 67 32 28
2021/2022578 27 55 28 62 20 39 35 135 32 41 22 82
2022/2023529 42 44 8 74 53 100 0 43 72 4 73 16
2023/2024285 16 29 6 44 21 91 35 17 17 9 0 0
Totale 4.426